Proteomic analysis of BRCA1-depleted cell line reveals a putative role for replication protein A2 up-regulation in BRCA1 breast tumor development

Proteomics - Clinical Applications

Volumn 4, Issue 5, 2010, Pages 489-498

  Bouley, Julien ^a   Pionneau, Cédric ^a   Varinot, Justine ^b   Biard, Denis ^c   Genestie, Catherine ^b   Antoine, Martine ^d   Coulet, Florence ^a,b   Stern, Marc Henri ^e   Stoppa Lyonnet, Dominique ^f   Soubrier, Florent ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c DIF   (France)

^d HÔPITAL TENON   (France)

^e INSTITUT CURIE   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

BRCA1; Inherited breast tumor; Replication protein A; Surrogate markers

Indexed keywords

BRCA1 PROTEIN; REPLICATION FACTOR A;

ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEOMICS; UPREGULATION;

BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; HELA CELLS; HUMANS; REPLICATION PROTEIN A;

EID: 77953791609     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900107     Document Type: Article

References (33)

1. Turnbull, C., Rahman, N., Genetic predisposition to breast cancer: past, present, and future. Annu. Rev. Genomics Hum. Genet. 2008, 9, 321-345.
2. Ford, D., Easton, D. F., Stratton, M., Narod, S. et al., Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 1998, 62, 676-689.
3. Turner, N., Tutt, A., Ashworth, A., Hallmarks of 'BRCAness' in sporadic cancers. Nat. Rev. Cancer 2004, 4, 814-819.
4. Deng, C. X., BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 2006, 34, 1416-1426.
5. Moynahan, M. E., Chiu, J. W., Koller, B. H., Jasin, M., Brca1 controls homology-directed DNA repair. Mol. Cell 1999, 4, 511-518.
6. Liu, X., Holstege, H., van der Gulden, H., Treur-Mulder, M. et al., Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc. Natl. Acad. Sci. USA 2007, 104, 12111-12116.
7. McPherson, J. P., Lemmers, B., Hirao, A., Hakem, A. et al., Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev. 2004, 18, 1144-1153.
8. Cao, L., Kim, S., Xiao, C., Wang, R. H. et al., ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. EMBO J. 2006, 25, 2167-2177.
9. Tommiska, J., Bartkova, J., Heinonen, M., Hautala, L. et al., The DNA damage signalling kinase ATMis aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triplenegative breast cancer. Oncogene 2008, 27, 2501-2506.
10. Crook, T., Crossland, S., Crompton, M. R., Osin, P., Gusterson, B. A., p53 mutations in BRCA1-associated familial breast cancer. Lancet 1997, 350, 638-639.
11. Holstege, H., Joosse, S. A., van Oostrom, C. T., Nederlof, P. M. et al., High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. Cancer Res. 2009, 69, 3625-3633.
12. Biard, D. S., Untangling the relationships between DNA repair pathways by silencing more than 20 DNA repair genes in human stable clones. Nucleic Acids Res. 2007, 35, 3535-3550.
13. Morency, E., Sabra, M., Catez, F., Texier, P., Lomonte, P., A novel cell response triggered by interphase centromere structural instability. J. Cell Biol. 2007, 177, 757-768.
14. Seshi, B., Proteomics strategy based on liquid-phase IEF and 2-D DIGE: application to bone marrow mesenchymal progenitor cells. Proteomics 2007, 7, 1984-1999.
15. Haring, S. J., Mason, A. C., Binz, S. K., Wold, M. S., Cellular functions of human RPA1: multiple roles of domains in replication, repair, and checkpoints. J. Biol. Chem. 2008, 283, 19095-19111.
16. Honrado, E., Osorio, A., Palacios, J., Benitez, J., Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 2006, 25, 5837-5845.
17. Youn, B., Kim, H. D., Kim, J., Nm23-H1/nucleoside diphosphate kinase as a key molecule in breast tumor angiogenesis. Expert. Opin. Ther. Targets 2008, 12, 1419-1430.
18. Fan, H., Huang, A., Villegas, C., Wright, J. A., The R1 component of mammalian ribonucleotide reductase has malignancysuppressing activity as demonstrated by gene transfer experiments. Proc. Natl. Acad. Sci. USA 1997, 94, 13181-13186.
19. Albiges, L., Andre, F., Balleyguier, C., Gomez-Abuin, G. et al., Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases. Ann. Oncol. 2005, 16, 1846-1847.
20. Zheng, X. M., Black, D., Chambon, P., Egly, J. M., Sequencing and expression of complementary DNA for the general transcription factor BTF3. Nature 1990, 344, 556-559.
21. Kusumawidjaja, G., Kayed, H., Giese, N., Bauer, A. et al., Basic transcription factor 3 (BTF3) regulates transcription of tumor-associated genes in pancreatic cancer cells. Cancer Biol. Ther. 2007, 6, 367-376.
22. Kostourou, V., Robinson, S. P., Whitley, G. S., Griffiths, J. R., Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging. Cancer Res. 2003, 63, 4960-4966.
23. Luo, M. L., Zhou, Z., Magni, K., Christoforides, C. et al., PremRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly. Nature 2001, 413, 644-647.
24. Li, C., Kato, M., Shiue, L., Shively, J. E. et al., Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays. Cancer Res. 2006, 66, 1990-1999.
25. Dirksen, E. H., Cloos, J., Braakhuis, B. J., Brakenhoff, R. H. et al., Human lymphoblastoid proteome analysis reveals a role for the inhibitor of acetyltransferases complex in DNA doublestrand break response. Cancer Res. 2006, 66, 1473-1480.
26. Wold, M. S., Replication protein A: a heterotrimeric, singlestranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 1997, 66, 61-92.
27. Dodson, G. E., Shi, Y., Tibbetts, R. S., DNA replication defects, spontaneous DNA damage, and ATM-dependent checkpoint activation in replication protein A-deficient cells. J. Biol. Chem. 2004, 279, 34010-34014.
28. Kim, K., Dimitrova, D. D., Carta, K. M., Saxena, A. et al., Novel checkpoint response to genotoxic stress mediated by nucleolin-replication protein a complex formation. Mol. Cell Biol. 2005, 25, 2463-2474.
29. Durant, S. T., Nickoloff, J. A., Good timing in the cell cycle for precise DNA repair by BRCA1. Cell Cycle 2005, 4, 1216-1222.
30. Choudhary, S. K., Li, R., BRCA1 modulates ionizing radiation-induced nuclear focus formation by the replication protein A p34 subunit. J. Cell Biochem. 2002, 84, 666-674.
31. Givalos, N., Gakiopoulou, H., Skliri, M., Bousboukea, K. et al., Replication protein A is an independent prognostic indicator with potential therapeutic implications in colon cancer. Mod. Pathol. 2007, 20, 159-166.
32. Zhao, G. Y., Sonoda, E., Barber, L. J., Oka, H. et al., A critical role for the ubiquitin-conjugating enzyme Ubc13 in initiating homologous recombination. Mol. Cell 2007, 25, 663-675.
33. Martin, R. W., Orelli, B. J., Yamazoe, M., Minn, A. J. et al., RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors. Cancer Res. 2007, 67, 9658-9665.